window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : September 14, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Digital Health

  • Central Nervous System,Digital & Data,Medical devices

    Natus expands AI-powered EEG analysis across Europe

    Natus has expanded access to its AI-powered EEG analysis tool [...]

    July 22, 2026
  • Digital & Data,Research & Development,Therapeutic Areas

    Fleming Initiative selects AWS to support global antimicrobial resistance platform

    The Fleming Initiative has selected Amazon Web Services (AWS) to [...]

    July 3, 2026
  • Digital & Data,Research & Development,Therapeutic Areas

    Study supports home-based EEG platform for Alzheimer’s clinical trials

    A peer-reviewed study has demonstrated that Cumulus Neuroscience’s NeuLogiq platform [...]

    July 3, 2026
  • Digital & Data,Medical devices,Pharmaceuticals and therapeutics

    Welbeck adopts OMED Health home-based SIBO testing pathway across UK network

    Welbeck Health Partners has rolled out OMED Health’s home-based SIBO [...]

    June 25, 2026
  • Biotech & Pharma Business,Digital & Data

    Veeva acquires Copli and launches AI-powered content review platform

    Veeva Systems has acquired Copli and launched a new AI-powered [...]

    June 25, 2026
  • Clinical & Regulatory,Digital & Data

    Kayentis launches AI-powered eConsent tool for clinical trials

    Kayentis has launched an AI-powered eConsent module designed to improve [...]

    June 25, 2026
  • Digital & Data,Genomics and sequencing

    Wellcome Genome Campus expands AI and genomics ambitions with new advisory group

    The Wellcome Genome Campus has established a Science and Technology [...]

    June 18, 2026
  • Clinical & Regulatory,Digital & Data

    Pistoia Alliance advances IDMP ontology ahead of EMA medicines data deadline

    The Pistoia Alliance has announced the next phase of its [...]

    June 10, 2026
  • Biotech & Pharma Business,Digital & Data,Drug Discovery & Development

    Ingenix raises €13M to expand AI platform for drug development

    Poland-based AI drug development company Ingenix has raised €13 million [...]

    June 8, 2026
  • Clinical & Regulatory,Drug Discovery & Development

    Japan pushes AI clinical trials agenda as global pharma leaders gather in Tokyo

    Japan’s push to modernise clinical research through artificial intelligence and [...]

    May 7, 2026
Previous123Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • FDA approves daraxonrasib for second-line pancreatic cancer
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics
  • PharmaForceIQ launches AI platform for pharma commercial teams
    Categories: Biotech & Pharma Business, Digital & Data
  • Biogen’s felzartamab approved in China for multiple myeloma
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Pharmaceuticals and therapeutics
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top